Becton Dickinson & Company 2023-03-22 Health serious FDA
Health · FDA · Recall #FDA-Z-1240-2023
BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for… Recall
Issued March 22, 2023 · Becton Dickinson & Company
In March 2023, Becton Dickinson & Company recalled the BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
What you should do
- 1 Stop using BD Ultra-Fine Insulin Syringe 0.5mL, 8mm, 31G-Insulin Syringes are designed for… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Becton Dickinson & Company to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Becton Dickinson & Company
- Category
- Health
- Recall date
- March 22, 2023
- Units affected
- Not reported
- Sold at
- Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador,
- Recall number
- FDA-Z-1240-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Becton Dickinson & Company has 6 recalls in our database, including 2 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.